GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing SL Pharmaceutical Co Ltd (SZSE:002038) » Definitions » Other Current Receivables

Beijing SL Pharmaceutical Co (SZSE:002038) Other Current Receivables : ¥31.7 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Beijing SL Pharmaceutical Co Other Current Receivables?

Beijing SL Pharmaceutical Co's Other Current Receivables for the quarter that ended in Mar. 2024 was ¥31.7 Mil.

Beijing SL Pharmaceutical Co's quarterly Other Current Receivables increased from Sep. 2023 (¥20.69 Mil) to Dec. 2023 (¥35.35 Mil) but then stayed the same from Dec. 2023 (¥35.35 Mil) to Mar. 2024 (¥31.68 Mil).

Beijing SL Pharmaceutical Co's annual Other Current Receivables increased from Dec. 2021 (¥33.33 Mil) to Dec. 2022 (¥33.63 Mil) and increased from Dec. 2022 (¥33.63 Mil) to Dec. 2023 (¥35.35 Mil).


Beijing SL Pharmaceutical Co Other Current Receivables Historical Data

The historical data trend for Beijing SL Pharmaceutical Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing SL Pharmaceutical Co Other Current Receivables Chart

Beijing SL Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.65 23.12 33.33 33.63 35.35

Beijing SL Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.38 25.52 20.69 35.35 31.68

Beijing SL Pharmaceutical Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Beijing SL Pharmaceutical Co Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Beijing SL Pharmaceutical Co's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing SL Pharmaceutical Co (SZSE:002038) Business Description

Traded in Other Exchanges
N/A
Address
No.69 Fu shi Road, No.1 Building, Bitongyuan, Haidian district, Beijing, CHN, 100049
Beijing SL Pharmaceutical Co Ltd is a Chinese biotechnology-pharmaceutical company. It is principally focused on developing and marketing gene engineering drugs. The product portfolio of the company includes drugs for Oncology, Hepatopathy and Senile disease. Its products include Filgrastim, Asparaginase, Dasartinib, Enoxaparin, Naftopidil, Ademetionine, Lenalidomide, and others.
Executives
Xu Ming Bo Directors, executives
Liang Shu Jie Secretary, Director
Yang Zhong Fan Supervisors
Chen Yu Lin Director
Qi Yan Ming Supervisors
Xi Wen Ying Executives
Wu Yan Zhuo Executives
Wang Wen Xin Director
Li Ya Jun Executives
Zhao Xia Securities Affairs Representative
Zhang Chun Lei Supervisors
Wang Yong Bo Directors, executives
Lu An Jing Supervisors
Wei Su Yan Director

Beijing SL Pharmaceutical Co (SZSE:002038) Headlines

No Headlines